Management of Post-Shingles Ocular Irritation
For persistent ocular irritation, erythema, and itching two months after herpes zoster ophthalmicus without pain or visual changes, you should treat this as postherpetic itch (PHI) with a combination of antihistamines and anticonvulsants (gabapentin or pregabalin), while ruling out active viral conjunctivitis or secondary complications.
Clinical Assessment Priority
First, perform a focused examination to exclude sight-threatening complications:
- Visual acuity measurement - any decline suggests corneal or intraocular involvement
- Slit-lamp biomicroscopy - look specifically for:
- Pseudodendrites or dendritic keratitis (active VZV)
- Stromal keratitis or corneal scarring
- Anterior uveitis or sectoral iris atrophy
- Elevated intraocular pressure (secondary glaucoma)
- Corneal anesthesia (test with cotton wisp)
- Assess for dry eye - late sequelae include dry eye and neurotrophic keratitis 1
Treatment Algorithm
If Active VZV Conjunctivitis is Present:
Oral antivirals are the mainstay 1:
- Acyclovir 800 mg five times daily for 7 days, OR
- Valacyclovir 1000 mg every 8 hours for 7 days, OR
- Famciclovir 500 mg three times daily for 7 days
Topical antivirals alone are NOT helpful for VZV conjunctivitis but may be added in unresponsive cases 1, 2. Consider topical antibiotics to prevent secondary bacterial infection, as vesicle necrosis can lead to severe conjunctival scarring and even cicatricial ectropion 1, 2.
If This is Postherpetic Itch (Most Likely):
Primary treatment based on the single highest-quality case evidence 3:
- Antihistamine (oral H1-antagonist such as cetirizine 10 mg daily or hydroxyzine 25-50 mg at bedtime)
- Plus anticonvulsant: Gabapentin starting 300 mg daily, titrating to 300-900 mg three times daily, OR pregabalin 75-150 mg twice daily
This combination successfully treated severe disabling PHI (10/10 intensity) in a documented case 3. PHI is associated with severe cutaneous deafferentation—loss of up to 96% of epidermal innervation—making it particularly resistant to treatment 4.
Adjunctive Symptomatic Management:
For ocular surface irritation:
- Preservative-free artificial tears frequently (at least 4 times daily) 5
- Lipid-based artificial tears if meibomian gland dysfunction is present 5
- Consider topical cyclosporine 0.05% twice daily for chronic inflammation 1
Avoid topical corticosteroids unless there is active stromal keratitis or severe inflammation with visual symptoms, as they can potentiate HSV infections and cause IOP elevation 1, 2. If corticosteroids are necessary, use site-specific agents like loteprednol etabonate at minimum effective dose with close IOP monitoring 1, 2.
Important Clinical Nuances
PHI epidemiology 6:
- More common when shingles affects head, face, and neck (your patient's distribution)
- Can be as disabling as postherpetic neuralgia
- May occur with or without accompanying pain
- Often associated with hyposensitivity to touch in affected areas 3
Duration considerations: Patients with chronic sequelae may require prolonged treatment and/or long-term prophylaxis 1. If symptoms persist beyond 3 months with adequate treatment, consider chronic disease requiring dose adjustment according to clinical response.
Follow-Up Schedule
- Within 1 week if any visual symptoms, pain, or signs of active infection develop
- Every 2-4 weeks initially to assess treatment response and monitor for complications
- Long-term monitoring for late sequelae including dry eye, corneal anesthesia, and neurotrophic keratitis 1
Common Pitfalls to Avoid
- Don't dismiss itching as trivial - severe PHI can lead to self-injury from scratching desensate skin, with documented cases of patients scratching through skull into brain 4
- Don't use topical antivirals alone for VZV - they are ineffective as monotherapy 1, 2
- Don't overlook corneal anesthesia - this predisposes to neurotrophic keratitis and requires aggressive lubrication
- Don't use preserved artificial tears more than 4 times daily - switch to preservative-free formulations 5